Systemic lupus erythematosus serum deposits C4d on red blood cells, decreases red blood cell membrane deformability, and promotes nitric oxide production

Arthritis and Rheumatism

Volumn 63, Issue 2, 2011, Pages 503-512

  Ghiran, Ionita C ^a   Zeidel, Mark L ^a   Shevkoplyas, Sergey S ^b   Burns, Jennie M ^b   Tsokos, George C ^a   Kyttaris, Vasileios C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b TULANE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C4D; FODRIN; NITRIC OXIDE; SPECTRIN; SPECTRIN BETA SUBUNIT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CALCIUM TRANSPORT; CAPILLARY; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT DEPOSITION; CONTROLLED STUDY; CYTOSKELETON; ERYTHROCYTE DEFORMABILITY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; MICROARRAY ANALYSIS; OXYGEN TISSUE LEVEL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; WESTERN BLOTTING;

ABO BLOOD-GROUP SYSTEM; ADULT; BLOOD DONORS; CALCIUM; CELLS, CULTURED; COMPLEMENT C4B; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; NITRIC OXIDE; PEPTIDE FRAGMENTS; PHOSPHORYLATION; SERUM; SEVERITY OF ILLNESS INDEX; SPECTRIN; YOUNG ADULT;

EID: 79551662557     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30143     Document Type: Article

References (37)

1. Manzi S, Navratil JS, Ruffing MJ, Liu CC, Danchenko N, Nilson SE, et al. Measurement of erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus. Arthritis Rheum 2004; 50: 3596-604.
2. Manzi S, Ahearn JM, Salmon J,. New insights into complement: a mediator of injury and marker of disease activity in systemic lupus erythematosus. Lupus 2004; 13: 298-303.
3. Liu CC, Manzi S, Kao AH, Navratil JS, Ruffing MJ, Ahearn JM,. Reticulocytes bearing C4d as biomarkers of disease activity for systemic lupus erythematosus. Arthritis Rheum 2005; 52: 3087-99.
4. Karnchanaphanurach P, Mirchev R, Ghiran I, Asara JM, Papahadjopoulos- Sternberg B, Nicholson-Weller A, et al. C3b deposition on human erythrocytes induces the formation of a membrane skeleton-linked protein complex. J Clin Invest 2009; 119: 788-801.
5. Vaya A, Lopez JM, Contreras MT, Falco C, Arguedas J, Corella D, et al. Erythrocyte deformability in survivors of acute myocardial infarction measured by two different methodologies. Clin Hemorheol Microcirc 2002; 27: 17-25.
6. Koksal C, Ercan M, Bozkurt AK,. Hemorrheological variables in critical limb ischemia. Int Angiol 2002; 21: 355-9.
7. Chasis JA, Mohandas N, Shohet SB,. Erythrocyte membrane rigidity induced by glycophorin A-ligand interaction: evidence for a ligand-induced association between glycophorin A and skeletal proteins. J Clin Invest 1985; 75: 1919-26.
8. Kalfa TA, Pushkaran S, Mohandas N, Hartwig JH, Fowler VM, Johnson JF, et al. Rac GTPases regulate the morphology and deformability of the erythrocyte cytoskeleton. Blood 2006; 108: 3637-45.
9. Hochberg MC, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997; 40: 1725.
10. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang DH, and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992; 35: 630-40.
11. Shevkoplyas SS, Yoshida T, Gifford SC, Bitensky MW,. Direct measurement of the impact of impaired erythrocyte deformability on microvascular network perfusion in a microfluidic device. Lab Chip 2006; 6: 914-20.
12. Davies KA, Peters AM, Beynon HL, Walport MJ,. Immune complex processing in patients with systemic lupus erythematosus. J Clin Invest 1992; 90: 2075-83.
13. Kavai M,. Immune complex clearance by complement receptor type 1 in SLE. Autoimmun Rev 2008; 8: 160-4.
14. Odhiambo CO, Otieno W, Adhiambo C, Odera MM, Stoute JA,. Increased deposition of C3b on red cells with low CR1 and CD55 in a malaria-endemic region of western Kenya: implications for the development of severe anemia. BMC Med 2008; 6: 23.
15. Mongan ES, Leddy JP, Atwater EC, Barnett EV,. Direct antiglobulin (Coombs) reactions in patients with connective tissue diseases. Arthritis Rheum 1967; 10: 502-8.
16. Shevkoplyas SS, Gifford SC, Yoshida T, Bitensky MW,. Prototype of an in vitro model of the microcirculation. Microvasc Res 2003; 65: 132-6.
17. Alster Y, Loewenstein A, Levin S, Lazar M, Korenstein R,. Low-frequency submicron fluctuations of red blood cells in diabetic retinopathy. Arch Ophthalmol 1998; 116: 1321-5.
18. Tuvia S, Levin S, Korenstein R,. Oxygenation-deoxygenation cycle of erythrocytes modulates submicron cell membrane fluctuations. Biophys J 1992; 63: 599-602.
19. Costa M, Ghiran I, Peng CK, Nicholson-Weller A, Goldberger AL,. Complex dynamics of human red blood cell flickering: alterations with in vivo aging. Phys Rev E Stat Nonlin Soft Matter Phys 2008; 78: 020901.
20. Manno S, Takakuwa Y, Nagao K, Mohandas N,. Modulation of erythrocyte membrane mechanical function by β-spectrin phosphorylation and dephosphorylation. J Biol Chem 1995; 270: 5659-65.
21. Chasis JA, Mohandas N,. Erythrocyte membrane deformability and stability: two distinct membrane properties that are independently regulated by skeletal protein associations. J Cell Biol 1986; 103: 343-50.
22. Salomao M, Zhang X, Yang Y, Lee S, Hartwig JH, Chasis JA, et al. Protein 4.1R-dependent multiprotein complex: new insights into the structural organization of the red blood cell membrane. Proc Natl Acad Sci U S A 2008; 105: 8026-31.
23. Mohandas N, Gallagher PG,. Red cell membrane: past, present, and future. Blood 2008; 112: 3939-48.
24. Condon MR, Feketova E, Machiedo GW, Deitch EA, Spolarics Z,. Augmented erythrocyte band-3 phosphorylation in septic mice. Biochim Biophys Acta 2007; 1772: 580-6.
25. Liu X, Miller MJ, Joshi MS, Sadowska-Krowicka H, Clark DA, Lancaster JR Jr,. Diffusion-limited reaction of free nitric oxide with erythrocytes. J Biol Chem 1998; 273: 18709-13. (Pubitemid 28366253)
26. Ozuyaman B, Grau M, Kelm M, Merx MW, Kleinbongard P,. RBC NOS: regulatory mechanisms and therapeutic aspects. Trends Mol Med 2008; 14: 314-22.
27. Kleinbongard P, Schulz R, Rassaf T, Lauer T, Dejam A, Jax T, et al. Red blood cells express a functional endothelial nitric oxide synthase. Blood 2006; 107: 2943-51.
28. Inman RD,. Immune complexes in SLE. Clin Rheum Dis 1982; 8: 49-62.
29. Shepherd GM,. The single capillary and the active brain. Proc Natl Acad Sci U S A 2003; 100: 12535-6.
30. Potter RF, Groom AC,. Capillary diameter and geometry in cardiac and skeletal muscle studied by means of corrosion casts. Microvasc Res 1983; 25: 68-84.
31. Tench CM, McCurdie I, White PD, D'Cruz DP,. The prevalence and associations of fatigue in systemic lupus erythematosus. Rheumatology (Oxford) 2000; 39: 1249-54.
32. Kozora E, Hanly JG, Lapteva L, Filley CM,. Cognitive dysfunction in systemic lupus erythematosus: past, present, and future [review]. Arthritis Rheum 2008; 58: 3286-98.
33. Kozora E, Arciniegas DB, Filley CM, West SG, Brown M, Miller D, et al. Cognitive and neurologic status in patients with systemic lupus erythematosus without major neuropsychiatric syndromes. Arthritis Rheum 2008; 59: 1639-46.
34. Ellsworth ML, Ellis CG, Goldman D, Stephenson AH, Dietrich HH, Sprague RS,. Erythrocytes: oxygen sensors and modulators of vascular tone. Physiology (Bethesda) 2009; 24: 107-16.
35. 2+ signaling profile of lupus T cells. J Immunol 2004; 173: 3676-83.
36. Perl A, Nagy G, Gergely P, Puskas F, Qian Y, Banki K,. Apoptosis and mitochondrial dysfunction in lymphocytes of patients with systemic lupus erythematosus. Methods Mol Med 2004; 102: 87-114.
37. Oates JC, Gilkeson GS,. The biology of nitric oxide and other reactive intermediates in systemic lupus erythematosus. Clin Immunol 2006; 121: 243-50.